About Lotus
Lotus is a company based in Taipei (Taiwan) founded in 1966 was acquired by Innobic Asia in November 2021. It operates as a Direct-to-Consumer (D2C) and Reseller / Distribution. The company has 31 employees as of April 09, 2024. Lotus has completed 1 acquisition, including Alvogen. Lotus offers products and services including Oncology Products and Generic Pharmaceuticals. Lotus operates in a competitive market with competitors including Inventia Healthcare, Capsugel, Suzhou Ze Jing Biological Pharmaceutical, Zim Labs and Adare Pharma Solutions, among others.
- Headquarter Taipei, Taiwan
- Employees 31 as on 09 Apr, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Lotus Pharmaceutical Co., Ltd.
-
Annual Revenue
$18.58 B9.59as on Dec 31, 2024
-
Net Profit
$5.07 B23.38as on Dec 31, 2024
-
EBITDA
$7.3 B19.46as on Dec 31, 2024
-
Latest Funding Round
Not available
-
Investors
Alvogen
& 2 more
-
Employee Count
31
as on Apr 09, 2024
- Investments & Acquisitions
- Acquired by
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Lotus
Lotus is a publicly listed company on the TWSE with ticker symbol 1795 in Taiwan, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Lotus
Lotus offers a comprehensive portfolio of products and services, including Oncology Products and Generic Pharmaceuticals.
High-quality oncology drugs are developed for global markets.
Affordable generic medicines are produced for various conditions.
People of Lotus
Unlock access to complete
Unlock access to complete
Funding Insights of Lotus
Investors in Lotus
Lotus has secured backing from 3 investors. Prominent investors backing the company include Alvogen, Aztiq and Innobic Asia.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Aztiq is engaged in investments within the pharmaceutical and biotech sectors.
|
Locked | Locked | Locked | |
|
Pharmaceutical products are developed and marketed globally.
|
Locked | Locked | Locked | |
|
Operates as a CDMO specializing in solid-based drug production.
|
Locked | Locked | Locked |
Investor details for Lotus
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Lotus
Lotus has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Alvogen.
Investment portfolio details for Lotus
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Pharmaceutical products are developed and marketed globally.
|
Locked | Locked | 2009 | Locked |
Complete acquisition details for Lotus
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Lotus
Detailed financials for Lotus
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Lotus Comparisons
Peer comparison for Lotus
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Lotus
Lotus operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Inventia Healthcare, Capsugel, Suzhou Ze Jing Biological Pharmaceutical, Zim Labs and Adare Pharma Solutions, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Oral solid drug delivery systems are manufactured and developed.
|
|
| Locked | Locked | Locked |
Dosage forms are delivered for preclinical, clinical, and commercial supply.
|
|
| Locked | Locked | Locked |
Company developing small molecules & eukaryotic cell based recombinant protein drugs
|
|
| Locked | Locked | Locked |
Solid and semisolid dosage forms are developed and manufactured.
|
|
| Locked | Locked | Locked |
CDMO manufacturing solid drugs
|
|
| Locked | Locked | Locked |
Product development, manufacturing and packaging services
|
Detailed competitors of Lotus
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Lotus
Complete news archive for Lotus
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Lotus
Lotus was founded in 1966 and raised its 1st funding round 55 years after it was founded.
Lotus is headquartered in Taipei, Taiwan.
Robert Wessman is the current CEO of Lotus.
As of Apr 09, 2024, the latest employee count at Lotus is 31.
Lotus is established as an international pharmaceutical entity with a focus on commercializing novel and generic drugs. Headquartered in Taiwan, the company is supported by a robust RD and manufacturing platform across Asia. A diverse portfolio of high-quality, affordable medicines is delivered to markets worldwide. Operations span oncology, generics, and contract research, with over 250 products in the market and more than 100 projects in development. Strategic partnerships and in-house capabilities are leveraged to maintain competitive speed and flexibility in the industry.
Lotus's top competitors include Inventia Healthcare, Zim Labs and Contract Pharmacal Corp..
Lotus offers Oncology Products and Generic Pharmaceuticals.
Yes, Lotus is publicly traded on TWSE under the ticker symbol 1795.
Lotus has made 1 acquisition, including Alvogen.
Lotus has 3 investors. Key investors include Alvogen, Aztiq, and Innobic Asia.
The ticker symbol of Lotus is 1795 on TWSE.